Showing results (121-130 of 146) with videos related to

Sort By:
Pageof 15
Neurology|November 24, 2004
Diabetes mellitus in midlife and the risk of dementia three decades laterM Schnaider Beeri, U Goldbourt, J M Silverman, et al.
The Journal of Clinical Psychiatry|October 1, 1987
Rebound anxiety in panic disorder patients treated with shorter-acting benzodiazepinesJ B Herman, A W Brotman, J F Rosenbaum
Journal of Clinical Psychopharmacology|June 1, 1987
The alprazolam to clonazepam switch for the treatment of panic disorderJ B Herman, J F Rosenbaum, A W Brotman
The American Journal of Gastroenterology|May 1, 1995
Portal venous gas as a complication of ERCP and endoscopic sphincterotomyJ B Herman, M S Levine, W B Long
American Journal of Epidemiology|March 1, 1993
Divergent age-associated patterns of high density lipoprotein cholesterol and its percentage in Jewish and Moslem Arab Israeli children and adolescents: the Petach Tikva ProjectP Greenland, U Goldbourt, S Yaari, et al.
The American Journal of Cardiology|April 15, 1993
Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial)U Goldbourt, S Behar, H Reicher-Reiss, et al.
Israel Journal of Medical Sciences|August 1, 1987
Alpha-tocopherol: effect on plasma lipoproteins in hypercholesterolemic patientsM J Cloarec, G M Perdriset, F A Lamberdiere, et al.
The American Journal of Medicine|November 3, 2001
A prospective study of plasma fibrinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention studyD Tanne, M Benderly, U Goldbourt, et al.
American Heart Journal|March 27, 2001
Prognosis of patients with a recurrent acute myocardial infarction before and in the reperfusion era--a national studyA Shotan, S Gottlieb, U Goldbourt, et al.
Journal of Clinical Epidemiology|June 1, 1995
Plasma fibrinogen levels and their correlates in 6457 coronary heart disease patients. The Bezafibrate Infarction Prevention (BIP) StudyE Barasch, M Benderly, E Graff, et al.
Pageof 15